France launches 2-year experiment with medical marijuana

France launches 2-year experiment with medical marijuana
In this Jan. 15, 2020, file photo, police officers and a police sniffer dog stand next to 63 kilos of marijuana which where found in the car seen left, during a press conference in Paris. France's government launched a two-year nationwide experiment with medical cannabis with a view to eventual legalization. (AP Photo/Michel Euler, File)

France's government launched a two-year nationwide experiment with medical marijuana Friday with a view to its eventual legalization.

Some 3,000 patients around the country will be given medical cannabis treatments and their health will be monitored by the national medicines watchdog, the Health Ministry said in a statement. The first prescription was issued Friday at the Clermont-Ferrand University Hospital in southern France.

The goal is to gather data about the effectiveness and safety of therapeutic marijuana, and to prepare eventual logistical circuits for future distribution, the ministry said.

Among those eligible will be , people with nerve pain that is not treatable by other methods, people with certain forms of epilepsy and people in .

Several European countries have already legalized medical marijuana.

The French project was approved by parliament in 2019 but delayed because of the coronavirus pandemic.


Explore further

Medical marijuana tied to fewer admissions in sickle cell disease

© 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Citation: France launches 2-year experiment with medical marijuana (2021, March 26) retrieved 20 September 2021 from https://medicalxpress.com/news/2021-03-france-year-medical-marijuana.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors